441 related articles for article (PubMed ID: 9492069)
1. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.
Yasuda H; Shima N; Nakagawa N; Mochizuki SI; Yano K; Fujise N; Sato Y; Goto M; Yamaguchi K; Kuriyama M; Kanno T; Murakami A; Tsuda E; Morinaga T; Higashio K
Endocrinology; 1998 Mar; 139(3):1329-37. PubMed ID: 9492069
[TBL] [Abstract][Full Text] [Related]
2. A novel molecular mechanism modulating osteoclast differentiation and function.
Yasuda H; Shima N; Nakagawa N; Yamaguchi K; Kinosaki M; Goto M; Mochizuki SI; Tsuda E; Morinaga T; Udagawa N; Takahashi N; Suda T; Higashio K
Bone; 1999 Jul; 25(1):109-13. PubMed ID: 10423033
[TBL] [Abstract][Full Text] [Related]
3. [Osteoclastogenesis inhibitory factor (OCIF)/OPG].
Tsuda E; Higashio K
Nihon Rinsho; 1998 Jun; 56(6):1435-9. PubMed ID: 9648461
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells.
Murakami T; Yamamoto M; Ono K; Nishikawa M; Nagata N; Motoyoshi K; Akatsu T
Biochem Biophys Res Commun; 1998 Nov; 252(3):747-52. PubMed ID: 9837778
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells.
Takai H; Kanematsu M; Yano K; Tsuda E; Higashio K; Ikeda K; Watanabe K; Yamada Y
J Biol Chem; 1998 Oct; 273(42):27091-6. PubMed ID: 9765225
[TBL] [Abstract][Full Text] [Related]
6. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.
Yasuda H; Shima N; Nakagawa N; Yamaguchi K; Kinosaki M; Mochizuki S; Tomoyasu A; Yano K; Goto M; Murakami A; Tsuda E; Morinaga T; Higashio K; Udagawa N; Takahashi N; Suda T
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3597-602. PubMed ID: 9520411
[TBL] [Abstract][Full Text] [Related]
7. Involvement of osteoprotegerin/osteoclastogenesis inhibitory factor in the stimulation of osteoclast formation by parathyroid hormone in mouse bone cells.
Kanzawa M; Sugimoto T; Kanatani M; Chihara K
Eur J Endocrinol; 2000 Jun; 142(6):661-4. PubMed ID: 10822231
[TBL] [Abstract][Full Text] [Related]
8. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.
Hofbauer LC; Khosla S; Dunstan CR; Lacey DL; Boyle WJ; Riggs BL
J Bone Miner Res; 2000 Jan; 15(1):2-12. PubMed ID: 10646108
[TBL] [Abstract][Full Text] [Related]
9. [Osteoclastogenesis Inhibitory Factor (OCIF) /Osteoprotegerin (OPG) as a new therapeutic agent for osteoporosis].
Mochizuki S; Kiyokawa A; Nagayama Y
Clin Calcium; 2005 Jan; 15(1):35-42. PubMed ID: 15632471
[TBL] [Abstract][Full Text] [Related]
10. Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis.
Yano K; Tsuda E; Washida N; Kobayashi F; Goto M; Harada A; Ikeda K; Higashio K; Yamada Y
J Bone Miner Res; 1999 Apr; 14(4):518-27. PubMed ID: 10234572
[TBL] [Abstract][Full Text] [Related]
11. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
[TBL] [Abstract][Full Text] [Related]
12. Basic fibroblast growth factor inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D(3) through suppressing the production of osteoclast differentiation factor.
Nakagawa N; Yasuda H; Yano K; Mochizuki Si; Kobayashi N; Fujimoto H; Yamaguchi K; Shima N; Morinaga T; Higashio K
Biochem Biophys Res Commun; 1999 Nov; 265(1):45-50. PubMed ID: 10548488
[TBL] [Abstract][Full Text] [Related]
13. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
Takayanagi H; Iizuka H; Juji T; Nakagawa T; Yamamoto A; Miyazaki T; Koshihara Y; Oda H; Nakamura K; Tanaka S
Arthritis Rheum; 2000 Feb; 43(2):259-69. PubMed ID: 10693864
[TBL] [Abstract][Full Text] [Related]
14. Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone.
Tsukii K; Shima N; Mochizuki S; Yamaguchi K; Kinosaki M; Yano K; Shibata O; Udagawa N; Yasuda H; Suda T; Higashio K
Biochem Biophys Res Commun; 1998 May; 246(2):337-41. PubMed ID: 9610359
[TBL] [Abstract][Full Text] [Related]
15. Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts.
Hakeda Y; Kobayashi Y; Yamaguchi K; Yasuda H; Tsuda E; Higashio K; Miyata T; Kumegawa M
Biochem Biophys Res Commun; 1998 Oct; 251(3):796-801. PubMed ID: 9790989
[TBL] [Abstract][Full Text] [Related]
16. Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density.
Suzuki K; Kurose T; Takizawa M; Maruyama M; Ushikawa K; Kikuyama M; Sugimoto C; Seino Y; Nagamatsu S; Ishida H
Diabetes Res Clin Pract; 2005 May; 68(2):117-25. PubMed ID: 15860239
[TBL] [Abstract][Full Text] [Related]
17. Periodontal ligament cells secrete the factor that inhibits osteoclastic differentiation and function: the factor is osteoprotegerin/osteoclastogenesis inhibitory factor.
Wada N; Maeda H; Tanabe K; Tsuda E; Yano K; Nakamuta H; Akamine A
J Periodontal Res; 2001 Feb; 36(1):56-63. PubMed ID: 11246705
[TBL] [Abstract][Full Text] [Related]
18. Expression of osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human dental mesenchymal cells and epithelial cells.
Sakata M; Shiba H; Komatsuzawa H; Fujita T; Ohta K; Sugai M; Suginaka H; Kurihara H
J Bone Miner Res; 1999 Sep; 14(9):1486-92. PubMed ID: 10469276
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation.
Nagai M; Sato N
Biochem Biophys Res Commun; 1999 Apr; 257(3):719-23. PubMed ID: 10208850
[TBL] [Abstract][Full Text] [Related]
20. Hypocalcemic effect of osteoclastogenesis inhibitory factor/osteoprotegerin in the thyroparathyroidectomized rat.
Yamamoto M; Murakami T; Nishikawa M; Tsuda E; Mochizuki S; Higashio K; Akatsu T; Motoyoshi K; Nagata N
Endocrinology; 1998 Sep; 139(9):4012-5. PubMed ID: 9724059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
